Boc-MLF
CAS No. 67247-12-5
Boc-MLF ( —— )
Catalog No. M22359 CAS No. 67247-12-5
Antagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 203 | In Stock |
|
5MG | 312 | In Stock |
|
10MG | 467 | In Stock |
|
25MG | 759 | In Stock |
|
50MG | 1044 | In Stock |
|
100MG | 1413 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBoc-MLF
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
-
DescriptionAntagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFPR1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67247-12-5
-
Formula Weight509.66
-
Molecular FormulaC25H39N3O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO:2 mg/mL
-
SMILESO=C([C@@H](NC([C@@H](NC(OC(C)(C)C)=O)CCSC)=O)CC(C)C)N[C@H]([C@@](O)=O)CC1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Boxio et al (2005) The immunostimulatory peptide WKYMVm-NH2 activates bone marrow mouse neutrophils via multiple signal transduction pathways. Scand.J.Immunol. 62 140 PMID:
molnova catalog
related products
-
Clinopodic acid E
The roots of Salvia miltiorrhiza Bge.
-
Tartrazine
Tartrazine is a food additive that belongs to a class of artificial dyes and contains an azo group.
-
Tubeimoside III
Tubeimoside III has anti-inflammatory anti-tumor and anti-tumorigenic activities stronger than those of tubeimoside II.